TSS
ABEO icon

Two Sigma Securities’s Abeona Therapeutics ABEO Stock Holding History

Two Sigma Securities’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,084
Closed -$9K – 2157
2022
Q1 		$9K Buy
+1,084
New +$7.44K ﹤0.01% 2048

Other funds holding ABEO

Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Two Sigma Securities's ABEO Position: Q2 2022 in Review

Two Sigma Securities sold out of Abeona Therapeutics (ABEO) in Q2 2022, closing a stake of 1,084 shares — an estimated $9K sold.

Two Sigma Securities first reported a position in ABEO in Q1 2022 and held it in 1 quarter. The position peaked at $9K in Q1 2022. 42 funds tracked by Wall St. Rank hold ABEO as of Q2 2022.

  • Two Sigma Securities reported no remaining Abeona Therapeutics position as of Q2 2022 after selling out during the quarter.
  • Two Sigma Securities sold 1,084 Abeona Therapeutics shares in Q2 2022, an estimated $9K.
  • Two Sigma Securities first reported a position in Abeona Therapeutics in Q1 2022 and held it in 1 quarter.
  • Two Sigma Securities's Abeona Therapeutics position peaked at $9K in Q1 2022.
  • 42 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q2 2022.

Based on Two Sigma Securities's 13F filing for Q2 2022, filed 15 Aug 2022.